TLR7 and systemic lupus erythematosus: Chronic epicutaneous application of the synthetic, small-molecule TLR7 agonist, R848 (Resiquimod), induces a robust SLE-like autoimmune phenotype in multiple genetic background strains of Mus musculus (36).